首页> 外文OA文献 >PRS45 - COST-EFFECTIVENESS OF BEDAQUILINE VERSUS INJECTABLE STANDARD-OF-CARE AGENTS FOR THE TREATMENT OF DRUG-RESISTANT TUBERCULOSIS (DR-TB) IN RUSSIA, INDIA, AND SOUTH AFRICA: BREAKTHROUGH INNOVATION DRIVING DOWN COST OF TREATMENT SUCCESS

【2h】

PRS45 - COST-EFFECTIVENESS OF BEDAQUILINE VERSUS INJECTABLE STANDARD-OF-CARE AGENTS FOR THE TREATMENT OF DRUG-RESISTANT TUBERCULOSIS (DR-TB) IN RUSSIA, INDIA, AND SOUTH AFRICA: BREAKTHROUGH INNOVATION DRIVING DOWN COST OF TREATMENT SUCCESS

机译：PRS45 - 贝壳喹啉的成本效益与俄罗斯，印度和南非治疗耐药结核病（DR-TB）的可注射标准治疗药物：突破性创新推动待遇成功的成本

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
A. Ionescu; M.A. Agnarson; C. Kambili; J. Kfoury; W. Steven; V. Singh; A. Williams; A. Thomas;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Impact of drug-resistant tuberculosis treatment on hearing function in South African adults: Bedaquiline versus kanamycin [J] . Katijah Khoza-Shangase, Marina Prodromos South African Journal of Communication Disorders . 2021,第1期

机译：抗药性结核治疗对南非成年人听力功能的影响：Bedaquiline对Kanamycin
2. Bedaquiline- versus injectable-containing drug-resistant tuberculosis regimens: a cost-effectiveness analysis [J] . Ionescu Ana-Maria, Agnarson Abela Mpobela, Kambili Chrispin, Expert review of pharmacoeconomics & outcomes research . 2018,第4a6期

机译：Bedaquiline-与含可注射的耐药结核方案：一种成本效益分析
3. Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study [J] . Ferlazzo Gabriella, Mohr Erika, Laxmeshwar Chinmay, The Lancet infectious diseases . 2018,第5期

机译：Bedaquiline和Delamanid组合的早期安全性和疗效治疗亚美尼亚，印度和南非耐药结核病患者：回顾性队列研究
4. Comparing the cost-effectiveness of different standardized tuberculosis treatment regimens in settings with varying prevalence of drug-resistant tuberculosis. [D] . Law, Yuen Shan Stephanie. 2011

机译：比较耐药结核病患病率不同情况下不同标准化结核病治疗方案的成本效益。
5. Impact of drug-resistant tuberculosis treatment on hearing function in South African adults: Bedaquiline versus kanamycin [O] . Katijah Khoza-Shangase, Marina Prodromos 2021

机译：抗药性结核治疗对南非成年人听力功能的影响：Bedaquiline对卡那霉素
6. Bedaquiline- versus injectable-containing drug-resistant tuberculosis regimens: a cost-effectiveness analysis [O] . Ana-Maria Ionescu, Abela Mpobela Agnarson, Chrispin Kambili, 2018

机译：Bedaquiline-与含可注射的耐药结核病方案：成本效益分析

PRS45 - COST-EFFECTIVENESS OF BEDAQUILINE VERSUS INJECTABLE STANDARD-OF-CARE AGENTS FOR THE TREATMENT OF DRUG-RESISTANT TUBERCULOSIS (DR-TB) IN RUSSIA, INDIA, AND SOUTH AFRICA: BREAKTHROUGH INNOVATION DRIVING DOWN COST OF TREATMENT SUCCESS

著录项

相似文献

相关主题

期刊订阅